series-a
Stage
1
Investors
About
Fluid Biomed develops a novel hybrid polymer-metal flow-diverting stent intended to treat brain aneurysms by promoting vascular healing and reducing risk of rupture and stroke, currently available only through authorized clinical investigations.
Explore Fluid Biomed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.